Cargando…
Oral Nanomedicines for siRNA Delivery to Treat Inflammatory Bowel Disease
RNA interference (RNAi) therapies have significant potential for the treatment of inflammatory bowel diseases (IBD). Although administering small interfering RNA (siRNA) via an oral route is desirable, various hurdles including physicochemical, mucus, and cellular uptake barriers of the gastrointest...
Autores principales: | Shinn, Jongyoon, Lee, Juyeon, Lee, Seon Ah, Lee, Seon Ju, Choi, Ah Hyun, Kim, Jung Seo, Kim, Su Jin, Kim, Hyo Jin, Lee, Cherin, Kim, Yejin, Kim, Joohyeon, Choi, Jonghee, Jung, Byungchae, Kim, Taeho, Nam, HyeonTaek, Kim, Hyungjun, Lee, Yonghyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503894/ https://www.ncbi.nlm.nih.gov/pubmed/36145716 http://dx.doi.org/10.3390/pharmaceutics14091969 |
Ejemplares similares
-
Smart pH-responsive nanomedicines for disease therapy
por: Shinn, Jongyoon, et al.
Publicado: (2022) -
Mesoporous Silica Nanoparticles as a Gene Delivery Platform for Cancer Therapy
por: Khaliq, Nisar Ul, et al.
Publicado: (2023) -
Pluronic F-68 and F-127 Based Nanomedicines for Advancing Combination Cancer Therapy
por: Khaliq, Nisar Ul, et al.
Publicado: (2023) -
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
por: Lee, Yonghyun, et al.
Publicado: (2023) -
Self-Assembling β-Glucan Nanomedicine for the Delivery of siRNA
por: Lee, Kyungwoo, et al.
Publicado: (2020)